Radiocontrast-induced nephropathy

Seminars in Nephrology

Volumn 18, Issue 5, 1998, Pages 551-557

  Solomon, Richard ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

CREATININE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; KIDNEY DISEASE; KIDNEY INJURY; KIDNEY ISCHEMIA; NEPHROTOXICITY; PRIORITY JOURNAL; PROPHYLAXIS; RADIATION INJURY; REVIEW; RISK FACTOR; SODIUM BALANCE;

CONTRAST MEDIA; HUMANS; KIDNEY FAILURE, ACUTE;

EID: 0031684691     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (78)

1. Fang LST, Sirota RA, Ebert TH, Lichenstein NS: Low fractional excretion of sodium with contrast media induced acute renal failure. Arch Intern Med 140:531-533, 1980
2. Schwab SJ, Hlatsky MA, Pieper KS, et al: Contrast nephrotoxicity: A randomized controlled trial of a nonionic and an ionic radiographie contrast agent. N Engl J Med 320:149-153, 1989
3. Levy EM, Viscoli CM, Horwitz RI: The effect of acute renal failure on mortality. A cohort analysis. JAMA 275:1489-1494, 1996
4. Davidson CJ, Hlatky M, Morris KG, et al: Cardiovascular and renal toxicity of a nonionic radiographie contrast agent after cardiac catheterization. A prospective trial. Ann Intern Med 110:119-124, 1989
5. Rudnick MR, Goldfarb S, Wexler L, et al: Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trial. Kidney Int 47:254-261, 1995
6. Barren BJ, Parfrey PS, Vavasour HM, et al: Contrast nephropathy in patients with impaired renal function: High versus low osmlar media. Kidney Int 41:1274-1279, 1992
7. Teruel JL, Marcer R, Onaindia JM, et al: Renal function impairment caused by intravenous urography. Arch Int Med 141:1271-1274, 1981
8. Moore RD, Steinberg EP, Powe NR, et al: Nephrotoxicity of high-osmolality versus low-osmolality contrast media: Randomized clinical trial. Radiology 182:649-655, 1992
9. Lautin EM, Freeman NJ, Schoenfeld AH, et al: Radiocontrast-associated renal dysfunction: Incidence and risk factors. Am J Roentgenol 157:49-58, 1991
10. Parfrey PS, Griffiths SM, Barren BJ, et al: Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both: A prospective controlled study. N Engl J Med 320:143-149, 1989
11. D'Elia JA, Gleason RE, Arday M, et al: Nephrotoxicity from angiographie contrast material: A prospective study. Am J Med 72:719-724, 1982
12. Rich MW, Crecelius CA: Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age and older. A prospective study. Arch Int Med 150:1237-1242, 1990
13. Moore RD, Steinberg EP, Powe NR, et al: Frequency and determinants of adverse reactions induced by high-osmolality contrast media. Radiology 170:727-732, 1989
14. Martin-Paredero V, Dixon SM, Baker JD, et al: Risk of renal failure after major angiography. Arch Surg 118:1417-1420, 1983
15. Taliercia CP, Vlietstra RE, Fisher LD, Burnett JC: Risk for renal dysfunction with cardiac angiography. Ann Intern Med 104:501-504, 1986
16. Solomon R, Werner C, Mann D, et al: Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med 331:1416-1420, 1994
17. Vix VA: Intravenous pyelography in multiple myeloma. Radiology 87:896-902, 1966
18. Myers GH, Witten DM: Acute renal failure after excretory urography in multiple myeloma. Am J Roentgenol Rad Ther Nucl Med 113:583-588, 1971
19. McCarthy CS, Becker JA: Multiple myeloma and contrast media. Radiology 183:519-521, 1992
20. Weisberg LS, Kurnik PB, Kurnik BRC: Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int 45:259-265, 1994
21. Cigarroa RG, Lange RA, Williams RH, Hillis LD: Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 86:649-652, 1989
22. Barren BJ, Carlisle EJ: Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 188:171-178, 1993
23. Morcos S, Brown P, Oldroyd S, et al: Relationship between the diuretic effect of radiocontrast media and their ability to increase renal vascular resistance. Br J Radiol 68:850-853, 1995
24. Caldicott WJH, Hollenberg NK, Abrams HL: Characteristics of response of renal vascular bed to contrast media: Evidence for vasoconstriction induced by renin-angiotensin system. Invest Radiol 5:539-547, 1970
25. Norby LH, DiBona OF: The renal vascular effects of meglumine diatrizoate. J Pharmocol Exp Ther 193:932-940, 1975
26. Sherwood T, Lavender JP: Does renal blood flow rise or fall in response to diatrizoate? Invest Radiol 4:327-328, 1970
27. Nygren A, Ulfendahl H, Hansell P, Erikson U: Effects of intravenous contrast media on cortical and medullary blood flow in the rat kidney. Invest Radiol 23:753-761, 1988
28. Heyman SN, Brezis M, Epstein FH, et al: Early renal medullary hypoxic injury from radiocontrast and indomethacin. Kidney Int 40:632-642, 1991
29. Heyman SN, Brezis M, Reubinoff CA, et al: Acute renal failure with selective medullary injury in the rat. J Clin Invest 82:401-412, 1988
30. Solomon R: Contrast-medium-induced acute renal failure. Kidney Int 53:230-242, 1998
31. Heyman SN, Clark B A, Kaiser N, et al: Radiocontrast agents induce endothelin release in vivo and in vitro. J Am Soc Nephrol 3:58-65, 1992
32. Heyman SN, Clark BA, Cantley L, et al: Effects of ioversol versus iothalamate on endothelin release and radiocontrast nephropathy. Invest Radiol 28:313-318, 1993
33. Margulies KB, Hildebrand FL, Heublein DM, Burnett JJC: Radiocontrast increases plasma and urinary endothelin. J Am Soc Nephrol 2:1041-1045, 1991
34. Russo D, Minutolo R, Cianciaruso B, et al: Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. J Am Soc Nephrol 6:1451-1458, 1995
35. Clark B, Kucksoo K, Epstein F: Endothelin and atrial natriuretic peptide levels following radiocontrast exposure in humans. Am J Kidney Dis 30:82-86, 1997
36. Marguiles K, McKinley L, Burnett J: Endothelin in human and canine radiocontrast-induced nephropathy. J Vase Res 29:163-164, 1992
37. Cantley LG, Spokes K, Clark B, et al: Role of endothelin and prostaglandins in radiocontrast-induced renal artery constriction. Kidney Int 44:1217-1223, 1993
38. Oldroyd SD, Haylor JL, Morcos SK: Bosentan, an orally active endothelin antagonist: Effect on the renal response to contrast media. Radiology 196:661-665, 1995
39. Oldroyd S, Slee SJ, Haylor J, et al: Role for endothelin in the renal responses to radiocontrast media in the rat. Clin Sci 87:427-434, 1994
40. Bird J, Oiancarli M, Megill J, Durham S: Effects of endothelin in radiocontrast-induced nephropathy in rats are mediated through endothelin-A receptors. J Am Soc Nephrol 7:1153-1157, 1996
41. Osswald H, Muhlbauer B, Schenk F: Adenosine mediates tubuloglomerular feedback response: An element of metabolic control of kidney function. Kidney Int 39:8128-5131, 1991
42. Erley CM, Duda SH, Schlepckow S, et al: Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast media application. Kidney Int 45:1425-1431, 1994
43. Erley CM, Burgert K, Anganke J, et al: Prevention of radiocontrast-induced nephropathy (RCIN) by adenosine antagonists. J Am Soc Nephrol 6:462, 1995 (abstr)
44. Deray G, Martinez F, Cacoub P, et al: A role for adenosine, calcium, and ischemia in radiocontrast-induced intrarenal vasoconstriction. Am J Nephrol 10:316-322, 1990
45. Katholi RE, Taylor GJ, McCann WP, et al: Nephrotoxicity from contrast media: Attenuation with theophylline. Radiology 195:17-22, 1995
46. Agmon Y, Peleg H, Greenfeld Z, et al: Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat. J Clin Invest 94:1069-1075, 1994
47. Brezis M, Heyman SN, Dinour D, et al: Role of nitric oxide in renal medullary oxygenation: Studies in isolated and intact rat kidneys. J Clin Invest 88:390-395, 1991
48. Morcos S, Oldroyd S, Haylor J: Effect of radiographic contrast media on endothelium derived nitric oxide-dependent renal vasodilatation. Br J Radiol 70:154-159, 1997
49. Heyman S, Rosen S, Brezis M: Radiocontrast nephropathy: A paradigm for the synergism between roxic and hypoxic insults in the kidney. Exp Nephrol 2:153-157, 1994
50. Humes HD, Hunt DA, White MD: Direct toxic effect of the radiocontrast agent diatrizoate on renal proximal tubule cells. Am J Physiol 252:F246-F255, 1987
51. Messana J, Cieslinski D, Nguyen U, Humes H: Comparison of the toxicity of the radiocontrast agents iopamidol and diatrizoate to rabbit proximal tubules in vitro. J Pharmacol Exp Ther 244:1139-1144, 1988
52. Severini G, Aliberti LM: Variation of urinary enzymes N-acetyl-beta-glucosaminidase, alanine-aminopeptidase, and lysozyme in patients receiving radio-contrast agents. Clin Biochem 20:339-341, 1987
53. Nicot GS, Merle LJ, Charmes JP, et al: Transient glomerular proteinuria, enzymuria, and nephrotoxic reaction induced by radiocontrast media. JAMA 252:2432-2434, 1984
54. Parvez Z, Ramamurthy S, Patel NB, Moncada R: Enzyme markers of contrast media-induced renal failure. Invest Radiol 25:S133-S134, 1990
55. Yoshimasa Y, Fogo A, Beckman JD: Reduced activity of antioxidant enzymes underlies contrast media-induced renal injury in volume depletion. Kidney Int 41:1008-1015, 1992
56. Bakris GL, Lass N, Gaber AO, et al: Radiocontrast medium-induced declines in renal function: A role for oxygen free radicals. Am J Physiol 258:F115-F120, 1990
57. Weisberg LS, Kurnik PB, Kurnik BRC: Dopamine and renal blood flow in radiocontrast-induced nephropathy in humans. Renal Fail 15:61-68, 1993
58. Hans B, Hans SS, Mittal VK, et al: Renal functional response to dopamine during and after arteriography in patients with chronic renal insufficiency. Radiology 176:651-654, 1990
59. Kapoor A, Sinha N, Sharma R, et al: Use of dopamine in prevention of contrast induced acute renal failure-A randomised study. Int J Cardiol 53:233-236, 1996
60. Hall KA, Wong RW, Hunter GC, et al: Contrast-inI duced nephropathy: The effects of vasodilator therapy. J Surg Res 53:317-320, 1992
61. Margulies KB, McKinley LJ, Allgren RL, et al: Intra-arterial atrial natriuretic factor (ANF) attenuates radiocontrast-induced nephropathy in humans. J Am Soc Nephrol 2:666, 1991 (abstr)
62. Kurnik B, Allgren R, Center F, et al: Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. Am J Kidney Dis (in press) 1998
63. Kurnik BR, Weisberg LS, Cuttier IM, Kurnik PB: Effects of atrial natriuretic peptide versus mannitol on renal blood flow during radiocontrast infusion in chronic renal failure. J Lab Clin Med 116:27-36, 1990
64. Jakobsen JA, Berg KJ, Brodahl U, et al: Renal effects of nonionic contrast media after cardioangiography. Acta Radiol 35:191-196, 1994
65. Wilding M, Kampf D, Jun MS, Junge W: Nitrendipine and nephrotoxicity of non-ionic contrast media: A randomized controlled clinical trial. J Am Soc Nephrol 6:671, 1995
66. Neumayer HH, Junge W, Kufner A, Wenning A: Prevention of radiocontrast-media-induced nephrotoxicity by the calcium channel blocker nitrendipine: A prospective randomized clinical trial. Nephrol Dial Transplant 4:1030-1036,1989
67. Carraro M, Mancini W, Artero M, et al: Dose effect of nitrendipine on urinary enzymes and microproteins following non-ionic radiocontrast administration. Nephrol Dial Transplant 11:444-448, 1996
68. Heyman SN, Brezis M, Greenfeld Z, Rosen S: Protective role of furosemide and saline in radiocontrast-induced acute renal failure in the rat. Am J Kidney Dis 14:377-385, 1989
69. Larson TS, Hudson K, Mertz JI, et al: Renal vasoconstriction response to contrast media. The role of sodium bal-ance and the renin-angiotensin system. J Lab Clin Med 101:385-391, 1983
70. Ghandour F, Larranaga J, Menon A, et al: The effect of mannitol (M) on the development of contrast-associated nephropathy (CAN) in patients with chronic renal insufficiency (CRI). J Am Soc Nephrol 6:464, 1995 (abstr)
71. Brezis M, Rosen S, Spokes K, et al: Transport-dependent anoxie cell injury in the isolated perfused rat kidney. AmJPathol 116:327-341, 1984
72. Brezis M, Heyman SN, Epstein FH: Determinants of intrarenal oxygenation. II. Hemodynamic effects. Am J Physiol 267:F1063-F1068, 1994
73. Weinstein J, Heyman S, Brezis M: Potential deleterious effect of furosemide in radiocontrast nephropathy. Nephron 62:413-415, 1992
74. Roberts D, Strife R, Gerber J, et al: Effect of sustained water diuresis on prostaglandin E2 excretion in humans. Am J Physiol 248:F830-F834, 1985
75. Waaler A, Svaland M, Fauchald P, et al: Elimination of iohexol, a low osmolar nonionic contrast medium, by hemodialysis in patients with chronic renal failure. Nephron 56:81-85, 1990
76. Moon SS, Back S, Kurkus J, Nilsson-Ehle P: Hemodialysis for elimination of the nonionic contrast medium iohexol after angiography in patients with impaired renal function. Nephron 70:430-437, 1995
77. Brooks MH, Barry KG: Removal of iodinated contrast material by peritoneal dialysis. Nephron 12:10-14, 1973
78. Dachman AH: New contraindication to intravascular iodinated contrast material. Radiology 197:545, 1995